Study Population Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).
Contract Database Metadata Elements Title: Spencerport Central School District and Spencerport Paraprofessional Association, New York State United Teachers (NYSUT), American Federation of Teachers (AFT), AFL-CIO (2015) Employer Name: Spencerport Central School District Union: Spencerport Paraprofessional Association, New York State United Teachers (NYSUT), American Federation of Teachers (AFT), AFL-CIO Local: Effective Date: 07/01/2015 Expiration Date: 06/30/2018 PERB ID Number: 6253 Unit Size: Number of Pages: 27 For additional research information and assistance, please visit the Research page of the Catherwood website - xxxx://xxx.xxx.xxxxxxx.xxx/library/research/ For additional information on the ILR School - xxxx://xxx.xxx.xxxxxxx.xxx/ AGREEMENT between the SUPERINTENDENT OF SCHOOLS SPENCERPORT CENTRAL SCHOOL DISTRICT Town of Ogden, Gates, Greece and Parma and SPENCERPORT PARAPROFESSIONAL ASSOCIATION July 1, 2015 - June 30, 2018 TABLE OF CONTENTS ARTICLE PAGE PREAMBLE 1 RECOGNITION 1 ELIGIBLITY FOR BENEFITS 1 ARTICLE 1 DUES DEDUCTION 2 ARTICLE 2 SICK LEAVE 2 ARTICLE 3 PERSONAL LEAVE 3 ARTICLE 4 ILLNESS IN FAMILY 4 ARTICLE 5 FAMILY MEDICAL LEAVE ACT 4 ARTICLE 6 HEALTH INSURANCE 5 ARTICLE 7 WORKER'S COMPENSATION 8 ARTICLE 8 BEREAVEMENT 9 ARTICLE 9 SNOW DAYS AND EMERGENCY CLOSING 9 ARTICLE 10 JURY DUTY 9 ARTICLE 1 WORK YEAR 9 ARTICLE 12 EXTRA HOURS WORKED 10 ARTICLE 13 1:1 AIDES 10 ARTICLE 14 LUNCH & BREAKS 10 ARTICLE 15 LONGEVITY 10 ARTICLE 16 PAID HOLIDAYS 1 ARTICLE 17 SALARY 12 ARTICLE 18 UNUSED SICK DAYS AT RETIREMENT 14 ARTICLE 19 GRIEVANCE PROCEDURE 15 ARTICLE 20 UNPAID LEAVE OF ABSENCE 17 ARTICLE 21 SENIORITY, ASSIGNMENT, AND LAYOFF 18 ARTICLE 22 VACANCY NOTIFICATIONS 20 ARTICLE 23 CREDIT FOR IN-SERVICE COURSES 20 ARTICLE 24 PROBATIONARY PERIOD 21 ARTICLE 25 FLEXIBLE SPENDING ACCOUNT 21 ARTICLE 26 ATTENDANCE INCENTIVE 21 ARTICLE 27 PERSONNEL FILES 22 ARTICLE 28 EVALUATIONS 22 ARTICLE 29 EARLY DISMISSAL - i - 22 ARTICLE 30 DIRECT DEPOSIT 23 ARTICLE 31 PAYROLL DEDUCTION 23 ARTICLE 32 PAYROLL DISTRIUBTION 23 ARTICLE 33 CONFORMITY OF LAW 23 ARTICLE 34 CHAPERONING AND PROCTORING 23 ARTICLE 35 BUS ATTENDANTS 24 ARTICLE 36 DURATION OF AGREEMENT 24 P R E A M B L E The Spencerport Central School District and the Spencerport Paraprofessional Association desire to enter into the agreement in order to effectuate the provisions of the Public Employees' Fair Employment Act and to encourage and increase the effective and harmonious work relationship between the district and the paraprofessionals who comprise the unit members within the bargaining unit represented by the association. The association hereby reaffirms that it will not engage in any strike, or cause, instigate, encourage, assist or condone any strike. The district recognizes the right of these unit members to organize and to bargain collectively through the association on such matters as salaries, hours and other terms and conditions of employment. The agreement is made and entered into on the 23rd day of June, 2015, by and between the Superintendent of Schools, SPENCERPORT CENTRAL SCHOOL DISTRICT, Spencerport, New York, hereinafter referred to as the "district," and the unit members of this unit of aforementioned school district, represented by the SPENCERPORT PARAPROFESSIONAL ASSOCIATION, hereinafter referred to as the "association." RECOGNITION Pursuant to the New York State Public Employees Fair Employment Act, the Board of Education of Spencerport Central School District has recognized the Spencerport Paraprofessional Association, hereinafter referred to as "association," as the exclusive negotiating representative for all Accompanists, Bus Attendants, Licensed Practical Nurses, Microcomputer Maintenance Technicians, School Aides and Teacher Aides employed by said district. ELIGIBILITY FOR BENEFITS All unit members employed by the District on June 30, 2000, while serving in a 27.5 (or more) hours per week position, will be considered as “full time” and will receive all of the benefits of unit members working 30 or more hours per week as detailed in Articles 2, 3, 4, 6, and 12 of this agreement. All unit members hired after June 30, 2000 are eligible for all of the benefits as detailed in Articles 2, 3, 4, 6, and 12 of this agreement and considered “full time” when serving in a 30 (or more) hours per week position. Any unit member hired after July 1, 2000 in a 30 (or more) hours per week capacity who is involuntarily reduced to at least 27.5 hours per week will receive the benefits associated with “full time” employment (Articles 2, 3, 4, 6, and 12). Spencerport Paraprofessional Association - 1 - July 1, 2012 - June 30, 2015
Technical Specifications 1. A procuring entity shall not prepare, adopt or apply any technical specification or prescribe any conformity assessment procedure with the purpose or effect of creating an unnecessary obstacle to trade between the Parties.
Research Use Reporting To assure adherence to NIH GDS Policy, the PI agrees to provide annual Progress Updates as part of the annual Project Renewal or Project Close-out processes, prior to the expiration of the one (1) year data access period. The PI who is seeking Renewal or Close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the PI is seeking renewal), any violations of the terms of access described within this Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. The PI also may include general comments regarding suggestions for improving the data access process in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing stewardship of data sharing activities subject to the NIH GDS Policy.
Geotechnical Engineer « »« » « » « » « » « »
Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.
Information Technology Enterprise Architecture Requirements If this Contract involves information technology-related products or services, the Contractor agrees that all such products or services are compatible with any of the technology standards found at xxxxx://xxx.xx.xxx/iot/2394.htm that are applicable, including the assistive technology standard. The State may terminate this Contract for default if the terms of this paragraph are breached.
Geotechnical Investigation Perform in accordance with the City Design Manual and other City requirements as designated in writing by the Director.
SERVICE MONITORING, ANALYSES AND ORACLE SOFTWARE 11.1 We continuously monitor the Services to facilitate Oracle’s operation of the Services; to help resolve Your service requests; to detect and address threats to the functionality, security, integrity, and availability of the Services as well as any content, data, or applications in the Services; and to detect and address illegal acts or violations of the Acceptable Use Policy. Oracle monitoring tools do not collect or store any of Your Content residing in the Services, except as needed for such purposes. Oracle does not monitor, and does not address issues with, non-Oracle software provided by You or any of Your Users that is stored in, or run on or through, the Services. Information collected by Oracle monitoring tools (excluding Your Content) may also be used to assist in managing Oracle’s product and service portfolio, to help Oracle address deficiencies in its product and service offerings, and for license management purposes.
Tests and Preclinical and Clinical Trials The preclinical studies and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company, that are described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, as applicable, and are intended to be submitted to FDA or other comparable government entities, were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all Authorizations and Applicable Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder and for studies submitted to regulatory authorities for approval, current Good Clinical Practices and Good Laboratory Practices and any applicable rules and regulations of the jurisdiction in which such trials and studies are being conducted; the descriptions of the results of such studies and trials contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus are, to the Company’s knowledge, accurate and complete in all material respects and fairly present the data derived from such studies and trials; except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company is not aware of any studies or trials, the results of which the Company believes reasonably call into question the study or trial results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus when viewed in the context in which such results are described and the clinical stage of development; and, except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company has not received any written notices or written correspondence from the FDA or any governmental entity requiring the termination or suspension of any preclinical studies or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.
